These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 20929607)

  • 21. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
    Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
    Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic approaches in hereditary angioedema.
    Antoniu SA
    Clin Rev Allergy Immunol; 2011 Aug; 41(1):114-22. PubMed ID: 21279474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Hereditary Angioedema.
    Caballero T
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical presentation, pathophysiology, diagnosis, and treatment of acquired and hereditary angioedema: Exploring state-of-the-art therapies in RI.
    Guo C; Settipane RA
    R I Med J (2013); 2016 Jun; 99(6):41-4. PubMed ID: 27247973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hereditary angioedema. A therapeutic guide].
    Malbrán A; Fernández Romero DS; Menéndez A
    Medicina (B Aires); 2012; 72(2):119-23. PubMed ID: 22522852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C1-esterase inhibitor (Cinryze
    Gupta R; Balduzzi J; Davis-Lorton M
    Immunotherapy; 2018 Jun; 10(8):635-642. PubMed ID: 29569504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema.
    Frank MM
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S23-9. PubMed ID: 18220149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J; Neeno T
    Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.
    Magerl M; Germenis AE; Maas C; Maurer M
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema].
    Leimgruber A
    Rev Med Suisse; 2011 Jan; 7(278):103-5. PubMed ID: 21400938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on hereditary angioedema.
    Hsu D; Shaker M
    Curr Opin Pediatr; 2012 Oct; 24(5):638-46. PubMed ID: 22935756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K; Tholanikunnel TE; Kaplan AP
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hereditary angioedema: a review (CME).
    Bhardwaj N; Craig TJ
    Transfusion; 2014 Nov; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.
    Farkas H
    Paediatr Drugs; 2018 Apr; 20(2):135-151. PubMed ID: 29214395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing hereditary angioedema patients undergoing otolaryngeal procedures.
    Bernstein JA
    Am J Rhinol Allergy; 2013; 27(6):522-7. PubMed ID: 23866957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New treatment options for acute edema attacks caused by hereditary angioedema.
    Thomas MC; Shah S
    Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary angioedema: new hopes for an orphan disease.
    Reshef A; Leibovich I; Goren A
    Isr Med Assoc J; 2008 Dec; 10(12):850-5. PubMed ID: 19160940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.